BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22689932)

  • 1. When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
    Ahmad T; Patel CB; Milano CA; Rogers JG
    Circulation; 2012 Jun; 125(23):2948-55. PubMed ID: 22689932
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Rosner et al regarding article, "When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure".
    Rosner GF; Garan AR; Uriel N
    Circulation; 2013 Jan; 127(4):e431. PubMed ID: 23357667
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
    Remme WJ
    Heart Fail Clin; 2005 Apr; 1(1):67-75. PubMed ID: 17386835
    [No Abstract]   [Full Text] [Related]  

  • 5. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
    Cayley WE
    Am Fam Physician; 2004 Jan; 69(1):71-2. PubMed ID: 14727819
    [No Abstract]   [Full Text] [Related]  

  • 6. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of beta-blocker therapy in severe chronic heart failure.
    Negut C
    N Engl J Med; 2001 Sep; 345(13):998; author reply 998-9. PubMed ID: 11575300
    [No Abstract]   [Full Text] [Related]  

  • 8. Ask the doctor. I had a heart attack three years ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol is 190, and my LDL is 128. Should I be taking a statin?
    Lee R
    Harv Heart Lett; 2011 Aug; 21(12):7. PubMed ID: 21991614
    [No Abstract]   [Full Text] [Related]  

  • 9. [Options in drug combinations].
    Correia JM
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():39-49. PubMed ID: 11409073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.
    Krum H; Mohacsi P; Katus HA; Tendera M; Rouleau JL; Fowler MB; Coats AJ; Roecker EB; Packer M;
    Am Heart J; 2006 Jan; 151(1):55-61. PubMed ID: 16368292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems and diseases. The heart, Part Ten. Heart failure-2.
    Gordon K; Child A
    Nurs Times; 2000 Apr 20-26; 96(16):49-52. PubMed ID: 11309947
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada.
    Levy AR; Briggs AH; Demers C; O'Brien BJ
    Am Heart J; 2001 Sep; 142(3):537-43. PubMed ID: 11526370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
    Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
    Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
    Demopoulos L; Yeh M; Gentilucci M; Testa M; Bijou R; Katz SD; Mancini D; Jones M; LeJemtel TH
    Circulation; 1997 Apr; 95(7):1764-7. PubMed ID: 9107160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone in the management of congestive cardiac failure: a review.
    Muller J
    Clin Ther; 1986; 9(1):63-76. PubMed ID: 2880664
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible dilated cardiomyopathy in a patient with Cushing's syndrome.
    Yong TY; Li JY
    Congest Heart Fail; 2010; 16(2):77-9. PubMed ID: 20412474
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Malebranche R; Tabou Moyo C; Morisset PH; Raphael NA; Wilentz JR
    Am Heart J; 2016 Aug; 178():151-60. PubMed ID: 27502863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

  • 19. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 20. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):265-8. PubMed ID: 11714003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.